Renal syndrome hemorrhagic fever, also known as epidemic hemorrhagic fever, is one of the major infectious diseases that endanger human health. It is a natural immunogenic disease caused by the epidemic hemorrhagic fever virus, hantavirus, with rodents as the main source of infection. The common clinical manifestations are divided into five phases: fever, hypotensive shock, oliguria, polyuria, and recovery. The general treatment principles include early detection, early treatment, early rest, and in situ isolation treatment. In the febrile period, physical cooling or adrenocorticotropic hormone can be applied; in case of hypotensive shock, attention should be paid to actively replenish blood volume. If there is significant bleeding, blood transfusion should be administered according to components; if platelets are significantly reduced, platelet transfusion should be administered; for patients with combined cardiac insufficiency, cardiac diuretic therapy should be administered; if renal oliguria occurs, it should be treated as acute renal failure, with appropriate restriction of fluid intake, appropriate application of diuretics, and maintenance of water-electrolyte and acid-base balance. If necessary, hemodialysis should be used; if liver function is impaired, hepatoprotective drugs should be given; in severe cases, antibiotics should be applied to prevent infection, as the death rate of this disease is as high as 20%-90%. The prognosis is even worse for those who have a high level of virus in the body or who have major organ damage such as liver and kidney function. The above is for reference only. Please refer to the doctor’s instructions for specific medication and treatment.